miR-22 suppresses cell viability and EMT of ovarian cancer cells via NLRP3 and inhibits PI3K/AKT signaling pathway
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 36
(3)
◽
pp. 956-965
◽
Keyword(s):
2009 ◽
Vol 69
(23)
◽
pp. 8910-8917
◽
Keyword(s):
Keyword(s):